Issue Price
₹55
Per Share
GMP
NIL
Grey Market
Est. Listing
₹55
Expected Price
Min. Application
₹220,000
2 lots × 2000 shares
Incorporated in 2009, Walpar Nutritions manufactures different types of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness, and food supplement products. It has developed 100+ formulations and 1000 brands under different segments i.e. Orthopaedics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Gynaecology, Neuro, Gastro-Intestinal, and sports nutrition. It further manufactures tablets, capsules, Ointments, creams, lotions, gels and sachet, powders, liquid orals, etc.The company has a manufacturing facility in Gandhinagar with an installed manufacturing capacity of 23 lakhs tablet/month, 12.50 lakhs capsules/month, 1.50 lakhs oral liquids/month, and 2 lakhs sachets/month.Competitive strengthsLarge product portfolio with 70+ products.Strong product manufacturing and development capabilities.Best quality products, certified by FSSAI and AYUSH department.
Walpar Nutritions Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 60,000 | — | ₹0.33 Cr | — |
| TOTAL | 1,200,000 | 100.00% | ₹6.60 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹110,000 |
| Retail (Max) | 13 | 26,000 | ₹1,430,000 |
| sNII (Min) | 14 | 28,000 | ₹1,540,000 |
| bNII (Min) | 68 | 136,000 | ₹7,480,000 |
| Particulars | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 |
|---|---|---|---|
| Revenue from Operations | 1671.27 | 1282.27 | 644.53 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 12.18 | 6.88 | 0.33 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 1317.41 | 918.09 | 390.37 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |